MedVital, a MedTech startup focused on advanced skin repair and wound care, has raised ₹8.4 crore in a pre-seed funding round led by Nihar Parikh’s 4point0 Health Ventures.
The round also saw participation from a marquee group of operator-investors, including founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
The funds raised will be used to expand its product portfolio, strengthen its supply chain, and broaden its distribution network to cover tertiary care hospitals, rural clinics, and home-care settings.
Founded in 2023 by Varun Gupta and Tarun Bansal, MedVital is a full-stack platform for wound care and minimally invasive aesthetics, integrating monitoring and next-generation biomaterials.
MedVital focuses on making advanced and innovative technologies for hard-to-heal wounds and minimally invasive aesthetics smarter and accessible.
Its flagship brand, NoWound, is a Negative Pressure Wound Therapy (NPWT) device designed to offer precision-controlled healing across hospital, clinic, and home-care settings. Unlike traditional NPWT systems, NoWound is compact, digitally enabled, and made in India, allowing seamless deployment even in resource-constrained environments.
MedVital also plans to launch liquid chitosan-based dressings for hard-to-heal wounds and expand into dermal and hair regeneration solutions, unlocking new clinical pathways in both therapeutic and aesthetic care.
Varun Gupta, Co-Founder and CEO of MedVital, said, “MedVital was founded on the belief that skin repair and restoration deserve the same level of innovation and investment as any other critical area of medicine. We are building a full-stack platform that integrates clinically proven devices, intelligent monitoring, and next-generation biomaterials to transform how complex wounds are treated and how patients recover. Our goal is to become a trusted partner for specialists restoring a patient’s skin, preventing diabetic amputations, or helping individuals regain confidence through aesthetic enhancements, our mission is simple: to make advanced solutions accessible and fairly priced for everyone. This funding allows us to accelerate that mission, strengthen our infrastructure, and scale with purpose.”
Tarun Bansal, Co-Founder and COO, said, “Our vision is to make India a global hub for cutting-edge wound care and skin restoration solutions. This funding gives us the fuel to scale responsibly, building a system that works not just in ICUs, but in homes and clinics across the country.”
Nihar Parikh, Founder of 4point0 Health Ventures, said, “We invest in teams that understand and address India’s healthcare challenges on a large scale. MedVital’s strategic approach to hard-to-heal wound management and minimally invasive treatments positions them uniquely in the healthcare landscape. Their focus on improving accessibility of high-quality science backed with measurable clinical outcomes addresses exactly what the market demands.”
